CrushSCI.com
51.0Average days
45.5Median days
14Fastest days
130Longest days
1612025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

66 days

Integrative Analysis of Cuproptosis-Related Genes and Repurposable Therapeutic Agents in Type A Aortic Dissection

Authors
Chengbin Tang; Yi Dai; Tao Chen; Jun Shao; Tao Zhu; Jingting Ye; Yusheng ShuShow moreShow less
Affiliations
1. Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Yangzhou, China; 2. Department of Center for Cardiac Macrovascular Disease, Northern Jiangsu People’s Hospital, Yangzhou, China; 3. Department of Thoracic Surgery, Northern Jiangsu People’s Hospital, Yangzhou, ChinaShow moreShow less
Source PDF DOI Publisher page
130 days

Salidroside Alleviates Atherosclerosis by Inhibiting Ferroptosis Through the RAG1/Keap1/Nrf2 Axis

Authors
Xiangnan Song; Qing Yang; Jie Yang; Jiali Xu; Yingyu Xiang; Yanhong Liu; Hui ChiShow moreShow less
Affiliations
1. Clinical Laboratory Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; 2. Department of Orthopedics, The Second Affiliated Hospital of Harbin Medical University, Harbin, ChinaShow moreShow less
Source PDF DOI Publisher page
17 days

Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories

Authors
Teruhiko ImamuraShow moreShow less
Affiliations
1. Second Department of Internal Medicine, University of Toyama, Toyama, JapanShow moreShow less
Source PDF DOI Publisher page
37 days

Ivabradine Versus Digitalis Glycosides in Heart Failure With Reduced Ejection Fraction: A Comparative Appraisal of Two Additional Medical Therapies

Authors
Vittorio Beltrani; Marco Bergonti; Martin R. Gruebler; Giordano M. Pugliesi; Luca Fazzini; Mattia Arrigo; Gregorio TersalviShow moreShow less
Affiliations
1. Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland; 2. Department of Cardiology, Istituto Cardiocentro Ticino, Lugano, Switzerland; 3. Department of Internal Medicine, Ente Ospedaliero Cantonale, Mendrisio, Switzerland; 4. Department of Cardiology, University Hospital Wiener Neustadt, Danube Private University, Wiener Neustadt, Austria; 5. Department of Internal Medicine, Medical University of Graz, Graz, Austria; 6. Medical Faculty, Sigmund Freud University, Vienna, Austria; 7. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, USA; 8. Non-Invasive Cardiac Imaging Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; 9. Cardiovascular Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy; 10. Department of Internal Medicine, Ente Ospedaliero Cantonale, Lugano, SwitzerlandShow moreShow less
Source PDF DOI Publisher page
17 days

Fixed-Dose Combination Versus Add-On Therapy: Clarifying the Role of Cilostazol–Rosuvastatin in Peripheral Artery Disease

Authors
Dezheng Lu; Chunyan KuangShow moreShow less
Affiliations
1. Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China; 2. Department of Cardiology, Guizhou Provincial People’s Hospital, Guiyang, ChinaShow moreShow less
Source PDF DOI Publisher page
62 days

Organelle Homeostasis and Metabolic Resilience: TFEB at the Crossroads of Lysosomal and Mitochondrial Adaptation

Authors
Matthew J. Brody; Nageswara R. MadamanchiShow moreShow less
Affiliations
1. Department of Pharmacology, University of Michigan Medical School, Ann Arbor, USA; 2. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CARDIOVASCULAR DRUGS AND THERAPY take to review a manuscript?

As of 2026-11-19, CrushSCI has 20 complete review records for CARDIOVASCULAR DRUGS AND THERAPY. The fastest paper went from submission to acceptance in 14 days (Rethinking Plaque Stabilization with Evolocumab in Diabetes: Methodological Considerations from the YELLOW III Trial, received 2026-09-27, accepted 2026-10-11); the slowest took 130 days. The average is 51.0 days and the median is 45.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.